Jackob Moskovitz

Jackob Moskovitz

Mar 21, 2019

Group 6 Copy 178
0
    Please wait...

    About This Project

    Oxidized forms of the peptide beta-amyloid (Aβ) are considered to be toxic to the brain, leading to the development of Alzheimer's disease (AD). Based on our preliminary data, we hypothesize that an immunization of an AD-model mice with a recombinant protein enriched with the oxidized amino acid methionine sulfoxide will cause the removal of toxic Aβ from brain. Consequently, this treatment is expected to inhibit the development of AD and alleviate cognitive impairment.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can we noninvasively measure blood sugar for diabetes?

    Better management of type 1 diabetes is moving towards anartificial pancreas. However, we need a better way...

    Can albumin from egg whites be used to treat Clostridium difficile infections?

    Clostridium difficile infection is a toxin-mediated bacterial infection responsible for 500,000 infections and...

    Are coyotes contributing to the spread Rocky Mountain spotted fever in Arizona?

    Rocky Mountain spotted fever (RMSF) is a tick-borne bacterial infection that can cause permanent disability...

    Campaign Ended

    A medicine project funded by 45 people